HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What is the process of reinfusion of my genetically engineered T-cells?

Posted by
HealthTree Logo HealthTree
• April 3, 2026

Description

Learn from Dr. Krina Patel about the process of reinfusing CAR T-cells during CAR-T therapy.

On this video

Healthtree contact Krina K. Patel, Specialist

Krina K. Patel, Specialist

MD Anderson Cancer Center

Related Content

  • Event Navigating CAR-T Therapy: Understanding Side Effects and Staying Informed
  • Video Cilta-Cel CAR-T for Myeloma: Which Patients Benefit From Earlier Treatment? | IMS 2026
  • Video CARTITUDE-2: Can Earlier Cilta-Cel CAR-T Lead to Long-Term Remission or Cure in Myeloma? | IMS 2026
  • Video Axi-Cel (Yescarta)-A CD19 Directed CAR-T Cell Product for Lymphoma
  • Video Should Everyone Get CAR-T at First Relapse in Multiple Myeloma? EMPOWER Consortium Data | IMS 2026